I really do see Medefile as an intellectual play.
For example - Stem cell stocks are so popular in the market with
very, very little revenue coming in, however people believe in there future.STEM CELLS! Not to say the stem cell market will not be huge.. ACTC is just one example of many..Just look at the speculation..
The incentives to go electronic are real, WILL HAPPEN and Medefile is a leader, and I have not heard one,not one reasonable argument against Medefiles chances at grabbing a massive market share.. - They turn a profit this year and its game on.
IMO
No buy back mentioned yet, however Kevin the CEO increased his stake